MED (MED)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$53.87M
EV / Sales0.16
EV / EBITDA8.50
EV / Operating Cash Flow14.49
EV / Free Cash Flow-36.62

Return Metrics (TTM)

Return on Equity (ROE)-9.68%
Return on Assets (ROA)-7.94%
Return on Invested Capital (ROIC)-6.57%
Return on Capital Employed (ROCE)-6.69%

Yield Metrics

Earnings Yield-18.51%
Free Cash Flow Yield-1.35%

Balance Sheet Strength

Net Debt / EBITDA-8.74
Current Ratio4.80
Working Capital$160.45M
Tangible Asset Value$197.68M
Net Current Asset Value$148.26M

Working Capital Efficiency

Days Sales Outstanding0.00
Days Payables Outstanding135.06
Operating Cycle (Days)75.55
Cash Conversion Cycle-59.52

Capital Allocation

CapEx / Revenue1.50%
CapEx / Operating Cash Flow139.57%
R&D / Revenue0.32%
SG&A / Revenue74.82%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin71.33%
Operating Margin-3.68%
Net Profit Margin-4.84%

Solvency

Debt / Equity0.08
Quick Ratio4.22
Cash Ratio2.08

Per Share

Revenue / Share$35.13
FCF / Share$0.11
PE Ratio-6.28